Save off-$28
MN-25 100g

MN-25 100g

Availability: In stock

Sku:

Be the first to review this product

Quantity

$560.00 $532.00

MN-25

MN-25 (UR-12) is a drug invented by Bristol-Myers Squibb, that acts as a reasonably selective agonist of peripheral cannabinoid receptors. It has moderate affinity for CB2 receptors with a Ki of 11 nM, but 22x lower affinity for the psychoactive CB1 receptors with a Ki of 245 nM. The indole 2-methyl derivative has the ratio of affinities reversed however, with a Ki of 8 nM at CB1 and 29 nM at CB2.

MN-25

It’s new legal cannabionoid

Other name: N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-methoxyindole-3-carboxamide

IUPAC name: 7-methoxy-1-(2-morpholinoethyl)-N-((1S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide

(N-[(S)-fenchyl]-1-[2-(morpholin-4-yl)ethyl]-7-methoxyindole-3-carboxamide)

CAS number: 501927-29-3 (2-methyl derivative)

Formula: C26H37N3O3

Purity: 99,7% min

Appearance: white powder

The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.

Reviews

There are no reviews yet.

Be the first to review “MN-25 100g”

custom contents goes here
Top